High level of plasma adiponectin in acute stroke patients is associated with stroke mortality

Journal of the Neurological Sciences

Volumn 304, Issue 1-2, 2011, Pages 102-106

  Nagasawa, Hikaru ^a   Yokota, Chiaki ^a   Toyoda, Kazunori ^a   Ito, Atsushi ^a   Minematsu, Kazuo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Acute stroke; Adipocyte; Adiponectin; Mortality; Prospective study; Risk factor

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; ATHEROTHROMBOTIC BRAIN INFARCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LACUNAR INFARCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STROKE; STROKE PATIENT; SURVIVAL RATE;

ACUTE DISEASE; ADIPONECTIN; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; SURVIVAL RATE;

EID: 79953329339     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.02.002     Document Type: Article

References (31)

1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33. (Pubitemid 38082408)
2. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9. (Pubitemid 36091630)
3. Chen MP, Tsai JCR, Chung FM, Yang SS, Hsing LL, Shin SJ, et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005;25:821-6.
4. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005;36:1915-20.
5. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, et al. Adiponectin prevents cerebral ischemic injury through endotherial nitric oxide synthase-dependent mechanisms. Circulation 2008;117:216-23.
6. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007;165:164-74. (Pubitemid 46096378)
7. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-62. (Pubitemid 41372115)
8. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006;92:1420-4. (Pubitemid 44578832)
9. Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007;167:1510-7. (Pubitemid 47124181)
10. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006;27:2300-9. (Pubitemid 44453573)
11. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponection and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006;17: 2599-606. (Pubitemid 44300977)
12. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MRS, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-10. (Pubitemid 32165613)
13. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
14. Yokota C, Minematsu K, Hasegawa Y, Yamaguchi T. Long-term prognosis, by stroke subtypes, after a first ever stroke: a hospital-based study over a 20-year period. Cerebrovasc Dis 2004;18:111-6. (Pubitemid 39077845)
15. Minematsu K, Yamaguchi T, Omae T. 'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157-62.
16. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, Lee KH. Adiponectin levels in patients with intracranial atherosclerosis. Neurology 2007;68:1931-7. (Pubitemid 46848626)
17. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004;10:524-9.
18. McEntegart MB, Awede B, Petie MC, Sttar N, Dunn FG, MacFarlane NG, et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007;28:829-35. (Pubitemid 47343601)
19. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CDA, Snijder MB, et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008;93:1489-96. (Pubitemid 351519753)
20. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008;93:3357-64.
21. Pilz S, Mangge H, Wellnitz B, Seelhorst U, Winkelmann BR, Tiran B, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006;91:4277-86. (Pubitemid 44833399)
22. Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, et al. Association of adiponectin with adverse outcome in coronary artery disease: results from the AtheroGene study. Eur Heart J 2008;29:649-57.
23. Maiolino G, Cesari M, Sticchi D, Zanchetta M, Pedon L, Antezza K, et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 2008;93:3333-40.
24. Marousi S, Theodorou G, Karakantza M, Papathanasopoulos P, Ellul J. Serum adiponectin acutely after an ischemic stroke: implications for long-lasting, suppressed anti-inflammatrory role. Acta Neurol Scand 2010;121:277-84.
25. Marousi SG, Theodorou GL, Karakantza M, Zampakis P, Papathanasopoulos P, Ellul J. Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome. Neurol Res 2010;32:841-4.
26. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004;316:165-9. (Pubitemid 38299140)
27. Wakabayashi S, Aso Y. Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diab Care 2004;27:2392-7. (Pubitemid 39281391)
28. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95. (Pubitemid 39258422)
29. Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi Maya, Orion D, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009;40:1296-303.
30. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249-59. (Pubitemid 43343322)
31. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006;55:1954-60. (Pubitemid 44509967)